Get started
Author

Erkan Kayıkçıoğlu

Observed names: Erkan KAYIKÇIOĞLU, Erkan Kayikcioglu, Erkan, Kayıkçıoğlu, Kayikcioglu, Erkan, Kayıkçıoglu, Erkan, Kayıkçıoğlu, Erkan
Observed institutions: Selçuk University, Süleyman Demirel Üniversitesi, Suleyman Demirel University Research and Education Hospital, Antalya Eğitim ve Araştırma Hastanesi, Suleyman Demirel University, Istinye University, Sağlık Bilimleri Üniversitesi, Liv Hospital
ORCID: 0000-0002-7401-5446
Observed ORCID: 0000-0002-7401-5446
OpenAlex ID: A5063142015
Prognostic value of claudin 18.2 expression in gastric adenocarcinoma
2023 · Erkan Kayikcioglu, Ramazan Oğuz Yüceer, et al. · World Journal of Gastrointestinal Oncology · 27
Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer
2023 · Seda Kahraman, Enes Erul, et al. · Future Oncology · 24
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
2023 · Cengiz Karacin, Berna Oksuzoglu, et al. · BMC Cancer · 23
PDF
The role of claudin 18.2 and HER-2 in pancreatic cancer outcomes
2023 · Erkan Kayikcioglu, Ramazan Oğuz Yüceer · Medicine · 18
Machine learning for predicting colon cancer recurrence
2024 · Erkan Kayikcioglu, Arif Hakan Onder, et al. · Surgical Oncology · 17
Efficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia on efficacy: a Turkish Oncology Group (TOG) study
2024 · Hasan Cagri Yildirim, Caner Kapar, et al. · Journal of Chemotherapy · 9
The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a Turkish oncology group (TOG) study
2024 · Hasan Çağrı Yıldırım, Yasin Kutlu, et al. · International Journal of Clinical Oncology · 9
A Novel Prognostic Index for Metastatic Colon Cancer: The Prognostic Immune Nutritional Index
2023 · Erkan Kayikcioglu, Gokce Iscan · Cureus · 8
PDF
Pan-Immune-Inflammation Value as a Novel Prognostic Biomarker for Advanced Pancreatic Cancer
2024 · Asim Armagan Aydin, Erkan Kayikcioglu, et al. · Cureus · 7
Assessment of polypharmacy, potentially inappropriate medications, and drug-drug interactions in older patients with cancer
2024 · Aslınur Albayrak, Bahar Erbay, et al. · Journal of Oncology Pharmacy Practice · 7
Examination of mental symptoms, anger, and death anxiety in elderly cancer patients
2023 · Gözde BACIK YAMAN, Erkan KAYIKÇIOĞLU, et al. · The Turkish Journal of Geriatrics · 6
PDF
An extremely rare neoplasm, histiocytic sarcoma: A report of two cases with an aggressive clinical course
2017 · Erkan Kayikcioglu, Asim Armagan Aydin, et al. · Journal of Oncological Sciences · 6
PDF
Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
2023 · Cengiz Karacin, Berna Oksuzoglu, et al. · BMC Cancer · 5
PDF
Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study
2025 · Seda Kahraman, Enes Erul, et al. · Clinical Breast Cancer · 4
The Prognostic Significance of CD47, CD68, and CD163 Expression Levels and Their Relationship with MLR and MAR in Locally Advanced and Oligometastatic Nasopharyngeal Carcinoma
2024 · Asim Armagan Aydin, Ramazan Oguz Yuceer, et al. · Diagnostics · 4
Cancer Patients’ Attachment Styles in the First Year After Diagnosis: The Impact of Perceived Stress and Emotion Regulation Skills
2025 · Gözde Bacık Yaman, Erkan Kayıkçıoğlu, et al. · Psychiatry and Clinical Psychopharmacology · 2
Prognostic value of computed tomography associated body composition measurement changes in metastatic colorectal cancer patients
2023 · Zekai Emre Sevgilioglu, Sehnaz Evrimler, et al. · Acta Radiologica · 2
Potential drug–drug interactions in patients with non-small cell lung cancer at a university hospital in Turkey
2023 · Aslınur Albayrak, Tuğdenur Düzenli, et al. · Journal of Cancer Research and Clinical Oncology · 2
PDF
The Pan-Immune-Inflammation Value Predicts the Survival of Patients with ER-positive, HER-2-Negative Metastatic Breast Cancer Treated with CDK4/6 inhibitors
2022 · Kayikcioglu, Erkan, Onder, Arif Hakan · Zenodo (CERN European Organization for Nuclear Research) · 2
Acute pancreatitis linked to bevacizumab: A case report
2018 · Arif Hakan Önder, Banu Öztürk, et al. · Journal of Oncological Sciences · 2
A Comparison of Maternal and Fetal Outcomes of Pregnancies Complicated by Moderate to Severe Thrombocytopenia Caused by Gestational Thrombocytopenia Preeclampsia / HELLP Syndrome and Immune Thrombocytopenic Purpura
2008 · Suna Özdemir, Hüseyin Görkemli, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 2
The Gustave Roussy immune score as a novel biomarker for predicting survival in patients with isocitrate dehydrogenase wild-type glioblastoma treated with the Stupp protocol
2025 · Asim Armagan Aydin, Ahmet Unlu, et al. · Expert Review of Anticancer Therapy · 1
HER2-low expression in patients with hormone receptor positive and HER2 negative advanced breast cancer treated with ribociclib or palbociclib in combination with endocrine therapy
2025 · Seda Kahraman, Mutlu Hızal, et al. · Turkish Journal of Clinics and Laboratory · 1
PDF
Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study
2024 · Özgecan Dülgar, Sema Türker, et al. · Journal of Chemotherapy · 1
Challenging VIPoma Case Treated with Sunitinib: A Life-Saving Therapeutic Experience
2024 · Melikşah YÜKSEL, Erkan KAYIKÇIOĞLU, et al. · Journal of Oncological Sciences · 1
PDF
Works count: 44
Citation count: 191
H-index: 8
I10-index: 5
Year
Topic
Type